Personalized medicines have dramatic impact on health care delivery, says Burrill
The convergence of genomics, information technology and nanotechnologies will radically alter every aspect of the health care system from the way companies develop and market drugs to the way individuals pay for and receive medical services, according to Biotech 2008 - Life Sciences: A 20/20 Vision for 2020 - the 22nd annual report on the biotechnology industry from San Francisco, USA-based Burrill & Co.
The just released publication examines the yearly performance of the biotech industry, makes predictions for the upcoming year, and provides insight on how scientific, business and policy developments today will alter the health care landscape in 2020. One of the important accelerating trends reshaping the biotechnology industry is the emergence of personalized medicine.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
| Headless Content Management with Blaze